Sri Havisha Hospital Intrinsic Value
Sri Havisha Hospital intrinsic value. Sri Havisha Hospital (HAVISHA) median intrinsic value is ₹1.97 from 4 valuation models (range ₹2–₹3), vs current price ₹1.40 — +40.7% upside (Trading Below Calculated Value), margin of safety 28.9%. Read HAVISHA dividend growth for the complete payout history and dividend yield track record.
HAVISHA Valuation Methods Summary — DCF, Graham Number & P/E
Sri Havisha Hospital intrinsic value across 4 models vs current price ₹1.40 — upside/downside and value range per method. Compare with HAVISHA fair price to assess whether the stock is under or overvalued.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹3.44 | ₹3.10 - ₹3.78 | +145.7% | Book Value/Share: ₹3.44, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹1.97 | ₹1.77 - ₹2.17 | +40.7% | Revenue/Share: ₹2.46, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹1.97 | ₹1.77 - ₹2.17 | +40.7% | EBITDA: ₹2.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹1.52 | ₹1.22 - ₹1.82 | +8.6% | CF Growth: 5.0%, Discount: 15% |
HAVISHA Intrinsic Value vs Market Price — All Valuation Models
Sri Havisha Hospital fair value range ₹2–₹3 vs current market price ₹1.40 across 4 valuation models. For current market price and key ratios, visit HAVISHA share price screener.
HAVISHA Intrinsic Value Analysis — Undervalued or Overvalued?
Sri Havisha Hospital median intrinsic value ₹1.97, current price ₹1.40 — Trading Below Calculated Value by 40.7%, margin of safety 28.9%.
What is the intrinsic value of HAVISHA?
Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of Sri Havisha Hospital (HAVISHA) is ₹1.97 (median value). With the current market price of ₹1.40, this represents a +40.7% variance from our estimated fair value.
The valuation range spans from ₹1.52 to ₹3.44, indicating ₹1.52 - ₹3.44.
Is HAVISHA undervalued or overvalued?
Based on our multi-method analysis, Sri Havisha Hospital (HAVISHA) appears to be trading below calculated value by approximately 40.7%.
HAVISHA Financial Health — Key Ratios vs Industry Benchmarks
Sri Havisha Hospital financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.30 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | -23.8% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -1.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.20x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
HAVISHA Cash Flow Quality — Operating & Free Cash Flow
Sri Havisha Hospital operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹1 Cr | ₹-1 Cr | Positive Operating Cash Flow | 6/10 |
| March 2025 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹4 Cr | ₹2 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹3 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |